Related references
Note: Only part of the references are listed.Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Maria P. Sormani et al.
ANNALS OF NEUROLOGY (2021)
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
Ana Zabalza et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab
Sridhar Chilimuri et al.
VACCINES (2021)
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
Riccardo Nistri et al.
FRONTIERS IN NEUROLOGY (2021)
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
Anat Achiron et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
Itay Lotan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
Giorgia T. Maniscalco et al.
FRONTIERS IN NEUROLOGY (2021)
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Maria Pia Sormani et al.
EBIOMEDICINE (2021)
Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study
Antonio Ziello et al.
BRAIN SCIENCES (2021)
The epidemiological relevance of the COVID-19-vaccinated population is increasing
Gunter Kampf
LANCET REGIONAL HEALTH-EUROPE (2021)
Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India
Chandramani Singh et al.
EPIDEMIOLOGY AND INFECTION (2021)
Current pharmacological treatments for COVID-19: What's next?
Cristina Scavone et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
Di Mauro Gabriella et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
Annalisa Capuano et al.
PHARMACOLOGICAL RESEARCH (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
Doriana Landi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
Giorgia Teresa Maniscalco et al.
PHARMACEUTICALS (2020)
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy
Cristina Scavone et al.
EXPERT OPINION ON DRUG SAFETY (2019)
The role of infections in multiple sclerosis
Mariano Marrodan et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Sex differences in vaccine-induced humoral immunity
Stephanie Fischinger et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner et al.
CNS DRUGS (2018)
Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy
Cristina Scavone et al.
FRONTIERS IN PHARMACOLOGY (2018)
T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship
Lina Petersone et al.
FRONTIERS IN IMMUNOLOGY (2018)
Drugs approved for the treatment of multiple sclerosis: review of their safety profile
Fabiana Auricchio et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15
Tara Harris et al.
VACCINE (2017)
Quitting smoking: An early non-motor feature of Parkinson's disease?
Marcello Moccia et al.
PARKINSONISM & RELATED DISORDERS (2015)
Sex and gender issues in multiple sclerosis
Hanne F. Harbo et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Pharmacovigilance in Italy: An overview
Carmela Mazzitello et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Epidemiology of multiple sclerosis in Europe: A Review
Ephrosyni Koutsouraki et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2010)
Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis
Helen Tremlett et al.
NEUROEPIDEMIOLOGY (2008)
The risk of relapses in multiple sclerosis during systemic infections
Jorge Correale et al.
NEUROLOGY (2006)